Augmedit Announces First Closing of Series A Round Led by Egeria Impact Investments, Joined by EIC Fund
We’re thrilled to announce the first closing of our Series A round, led by Egeria Impact Investments, with the EIC Fund (European Innovation Council Fund) joining as a key strategic investor, alongside our existing investors who have reaffirmed their support this round.
This milestone marks a pivotal step in our mission to bring AI-driven Augmented Reality (AR) software to the heart of surgery—transforming 2D medical images into intuitive 3D holograms that enhance precision, reduce preventable errors, and improve surgical outcomes.
🧠 Built on smart AI, built for global scale
At the core of our platform is a powerful set of AI algorithms that automatically segment anatomical structures—a capability that not only improves surgical planning and intra-op visualization, but also lays a strong foundation for scaling our product portfolio across new clinical areas by adding procedure-specific algorithms.
💡 Fueling the next phase of growth
This funding will drive:
· Commercial rollout of our neurosurgical AR platform
· Expansion into new surgical specialties, including orthopedics, maxillofacial surgery and oncology
· Global scaling, with a focus on the US and Southeast Asia
Claartje Ypma, CEO and Co-founder:"This funding marks a major step in our mission to bring smarter surgery to operating rooms worldwide. With Egeria’s commercial expertise and the EIC Fund’s support, we’re now positioned to scale our impact—both by accelerating market entry and by expanding into new surgical domains. We’re incredibly proud of what the team has achieved and energized for what’s ahead."
Peter Visser, Chairman and Founding Partner at Egeria Impact Investments, commented: "We believe Augmedit has the potential to redefine surgical workflows with its AR platform. The team has built a strong foundation with impressive early adoption, and we look forward to supporting them in commercializing this breakthrough technology across global markets."
💸 Second Closing
This round remains open for a limited time. New investors now have the opportunity to join, with the EIC Fund matching all new investment 1:1. A strong signal of institutional confidence and momentum.
To our partners, customers, and investors—thank you for believing in our vision. Together, we’re building the 3D future of surgery!
